Search clinical trials for: Clopidogrel and Esomeprazole

Total 272473 results

Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
AstraZeneca

Completed

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Healthy

United States
Queen's University
Canadian Institutes of Health Research (CIHR)

Terminated

Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

Gastric Acid

Canada
AstraZeneca

Completed

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

Gastrointestinal Hemorrhage

China
Victoria Rollason

Active, not recruiting

PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms (PROGRESS)

Stomach Diseases

Switzerland
LCMC Health

Terminated

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection (CENERDD)

Gastroesophageal Reflux | Non-erosive Reflux Disease

United States
Changi General Hospital

Unknown

A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis (TRIVON)

Helicobacter Pylori Infection

Singapore
Temple University

Withdrawn

Comparison of Voice Therapy and Antireflex Therapy in LPR

Laryngopharyngeal Reflux

United States
Effexus Pharmaceutical
Southern Arizona VA Health Care System

Unknown

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Heartburn | Gastroesophageal Reflux Disease (GERD) | Indigestion

United States
National Taiwan University Hospital
Haemonetics Corporation

Unknown

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

30 Healthy People

Taiwan
HK inno.N Corporation

Completed

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

Healthy

Korea, Republic of
Shinshu University

Recruiting

Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

Gastrointestinal Erosions and/or Ulcers

Japan
HK inno.N Corporation

Not yet recruiting

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

Healthy

Korea, Republic of
University of Maryland, Baltimore
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Clopidogrel Pharmacogenetics (PGX) Bench to Bedside (PGXB2B)

Metabolism of Clopidogrel

United States
Sanofi
Bristol-Myers Squibb

Completed

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

Healthy

United States
Sanofi
Bristol-Myers Squibb

Completed

Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

Healthy

United States
West China Hospital

Not yet recruiting

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

Upper Gastrointestinal Hemorrhage
IBSA Institut Biochimique SA

Completed

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Hypothyroidism;Postablative

United States
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Maintenance Treatment)

Reflux Esophagitis

Japan
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Centre de Recherche de l'Institut Universitaire...

Completed

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects (SPICE)

Coronary Artery Disease

Canada
Neil Kleiman, MD

Completed

Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole

Coronary Artery Disease

United States
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Initial Treatment)

Reflux Esophagitis

Japan
National Taiwan University Hospital
Ministry of Science and Technology, Taipei, Taiwan

Completed

Intragastric pH and Bismuth Effect for H. Pylori Eradication

Helicobacter Pylori Infection

Taiwan
Takeda

Completed

A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants

Healthy Participants

United States
University Hospital, Toulouse

Completed

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement (TIRATROP)

Atherosclerosis

France
AstraZeneca

Completed

Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)

Refractory Reflux Esophagitis

Japan
AstraZeneca

Completed

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

Healthy Volunteers

Sweden
Chinese University of Hong Kong

Completed

Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy (IOE)

Bleeding | Peptic Ulcer

China
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

Healthy Subjects
Onconic Therapeutics Inc.

Completed

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

GERD

Korea, Republic of
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Healthy Subjects
Chong Kun Dang Pharmaceutical

Completed

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

GERD

Korea, Republic of
Beijing Children's Hospital

Unknown

Tailored Therapy for Helicobacter Pylori in Children

Helicobacter Pylori Infection

China
AstraZeneca

Completed

Phase 3/Safety & Efficacy of Esomeprazole in Infants

Gastroesophageal Reflux Disease (GERD)

United States, France, Poland, Germany
Chinese University of Hong Kong

Terminated

A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole

Gastrointestinal Hemorrhage

China
Daewoong Pharmaceutical Co. LTD.

Completed

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

Erosive Esophagitis

Korea, Republic of
Erasmus Medical Center

Completed

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib (REGORA)

Colorectal Neoplasms | Gastrointestinal Stromal Tumors

Netherlands
AstraZeneca

Completed

An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

Gastric Ulcer

United States
AstraZeneca

Completed

The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

Quality of Life | GERD

Netherlands
Taipei Medical University

Unknown

A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

Upper Gastrointestinal Bleeding

Taiwan
AstraZeneca

Completed

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Gastroesophageal Reflux Disease (GERD)

United States, France, Italy, Canada
Southern Arizona VA Health Care System

Unknown

Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD (ISS)

Gastroesophageal Reflux Disease

United States
Zealand University Hospital

Unknown

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena

Healthy

Denmark
Peking Union Medical College Hospital

Recruiting

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

China
AstraZeneca

Completed

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

Bioequivalence Study

Japan
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Gastritis

Korea, Republic of
Glostrup University Hospital, Copenhagen

Unknown

Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice

Ulcer | Dyspepsia | Gastroesophageal Refluxdisease

Denmark
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

Healthy

Germany

3

Subscribe